Physician profile
Michael Bagheri
NPI 1740463322
$31,492.66
in general payments reported to CMS, 2019-2025
46 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,593 · 2021: $2,525 · 2022: $1,885 · 2023: $1,905 · 2024: $4,234 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,668 · Travel and Lodging: $2,100 · Education: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,667.74 |
| Travel and Lodging | $2,100.23 |
| Education | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $17,069.83 | 2019-2022 | |
| Abbott Laboratories | $2,837.13 | 2019-2025 | Aveir, Xience Skypoint, Coroflow |
| Novartis Pharmaceuticals Corporation | $1,450.12 | 2019-2025 | |
| Boston Scientific Corporation | $980.65 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Latitude Communicator Power Supply |
| Astrazeneca Pharmaceuticals LP | $962.94 | 2019-2025 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $948.39 | 2019-2024 | Xarelto |
| Medtronic, INC. | $706.66 | 2021-2025 | Corevalve Evolut R, Micra, Reveal Linq |
| Edwards Lifesciences Corporation | $674.58 | 2019-2023 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $643.75 | 2021-2025 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $560.47 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $481.39 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $432.16 | 2020-2025 | Nexletol |
| Pfizer INC. | $381.41 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $334.57 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $325.16 | 2019-2024 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $284.95 | 2019-2022 | |
| Novo Nordisk INC | $269.84 | 2021-2025 | Wegovy, Ozempic |
| Amarin Pharma, INC. | $195.90 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $185.11 | 2021-2025 | Evkeeza |
| Philips North America LLC | $171.21 | 2022-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Amgen INC. | $170.85 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $162.86 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $116.22 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $111.37 | 2022-2025 | |
| Akcea Therapeutics, INC. | $92.35 | 2020-2021 | |
| Lundbeck LLC | $90.10 | 2019 | |
| Amryt Pharma Holdings LTD | $82.31 | 2021-2023 | Juxtapid |
| Chiesi USA, INC. | $82.04 | 2019-2024 | Juxtapid, Cleviprex, Kengreal |
| Impulse Dynamics (USA) INC. | $81.48 | 2022-2023 | Optimizer |
| Zoll Respicardia, INC. | $75.87 | 2025 | Remede System |
| Agios Pharmaceuticals, INC. | $56.58 | 2025 | Pyrukynd |
| Biotronik INC. | $50.97 | 2019-2020 | |
| Angiodynamics, INC. | $47.06 | 2023 | Alphavac |
| Kestra Medical Technology Services, INC. | $40.72 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $40.55 | 2021-2023 | Arcalyst |
| Cardiva Medical, INC. | $37.99 | 2024-2025 | Optowire |
| Inspire Medical Systems, INC. | $37.58 | 2025 | Inspire |
| Haemonetics Corporation | $29.30 | 2025 | Teg6s Hemostasis System |
| Baxter Healthcare | $27.72 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $27.10 | 2024 | Arcalyst |
| Heartflow, INC. | $26.77 | 2024 | |
| Livanova USA, INC. | $25.06 | 2022 | |
| Lilly USA, LLC | $24.31 | 2025 | Zepbound, Mounjaro |
| Scpharmaceuticals INC. | $22.49 | 2025 | |
| Preventice Services, LLC | $19.49 | 2021 | |
| Cvrx, INC. | $17.30 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bagheri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.